3D Medicines (01244) announced interim results: 中期業績公告截至2026年6月30日止六個月, net profit attributable to owners RMB-85.2M Title: 中期業績公告截至2026年6月30日止六個月 Revenue: RMB2.1bn Net profit: RMB-88.5M Profit attributable to owners: RMB-85.2M
